¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"bacterial vaccines"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacterial
    ¼¼±Õ-
  • bacterial antagonism
    ¼¼±Õ´ëÇ×ÀÛ¿ë, ¼¼±Õ¸Â¹öÆÀÀÛ¿ë
  • bacterial artificial chromosome
    ¹ÚÅ׸®¾Æ¼ºÀΰø¿°»öü
  • bacterial colony
    ¼¼±ÕÁý¶ô
  • bacterial conjugation
    ¼¼±ÕÁ¢ÇÕ
  • bacterial cytology
    ¼¼±Õ¼¼Æ÷ÇÐ
  • bacterial decomposition
    ¼¼±ÕºÐÇØ
  • bacterial endocarditis
    ¼¼±Õ½É³»¸·¿°
  • bacterial flora
    ¼¼±Õ¹«¸®
  • bacterial growth rate
    ¼¼±ÕÁõ½Ä·ü
  • bacterial strain
    ¼¼±ÕÁÖ
  • bacterial translocation
    ¼¼±ÕÀüÀ§
  • bacterial vaginosis
    ¼¼±ÕÁúÁõ
  • subacute bacterial endocarditis
    ¾Æ±Þ¼º¼¼±Õ½É³»¸·¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacterial colony
    ¼¼±ÕÁý¶ô
  • bacterial translocation
    ¼¼±Õ ÀüÀ§
  • bacterial vaginosis
    ¼¼±ÕÁúÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacterial antagonism
    ¼¼±Õ¸Â¹öÆÀÀÛ¿ë
  • bacterial
    ¼¼±Õ-
  • bacterial colony
    ¼¼±ÕÁý¶ô
  • bacterial conjugation
    ¼¼±ÕÁ¢ÇÕ
  • bacterial cytology
    ¼¼±Õ¼¼Æ÷ÇÐ
  • bacterial decomposition
    ¼¼±ÕºÐÇØ
  • bacterial disease
    ¼¼±Õº´
  • bacterial exotoxin
    ¼¼±Õ¿Üµ¶¼Ò
  • bacterial flora
    ¼¼±Õ¹«¸®
  • bacterial shock
    ¼¼±Õ¼îÅ©
  • bacterial species
    ¼¼±ÕÁ¾
  • bacterial strain
    ±ÕÁÖ
  • bacterial growth rate
    ¼¼±ÕÁõ½Ä·ü
  • bacterial interference therapy
    ¼¼±Õ°£¼·¿ä¹ý
  • total bacterial count
    Ãѱռö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SBE= subacute bacterial endocarditis
    ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°.
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(Ðáàõá¬Ð¶àõÎ¼ï½æú).
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(¡­á¬Ð¶àõÎ¼ï½æú).
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°(¡­á¬Ð¶àõãýҮدæú).
  • gelatinoid plaque =dental p., bacterial p.
    Ä¡¾Æ¼¼±Õ¸·(öÍä³á¬Ð¶Ø¯).
  • genetics, bacterial
    ¼¼±ÕÀ¯ÀüÇÐ
  • plasmid, bacterial
    ¼¼±ÕÇö󽺹̵å
  • preputial bacterial colonization
    Æ÷ÇǼ¼±ÕÀüÁö±º°Å
  • recurrent bacterial meningitis
    Àç¹ß¼º ¼¼±Õ¼º ¼ö¸·¿°(î¢Û¡àõá¬Ð¶àõâÐØ¯æú).
  • recurrent bacterial meningitis
    Àç¹ß¼º ¼¼±Õ¼º ¼ö¸·¿°(î¢Û¡àõá¬Ð¶àõâÐØ¯æú)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(¡­á¬Ð¶àõÎ¼ï½æú).
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(Ðáàõá¬Ð¶àõÎ¼ï½æú).
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°(¡­á¬Ð¶àõãýҮدæú).
  • bacterial
    ¼¼±Õ(¼º)(á¬Ð¶àõ)ÀÇ.
  • bacterial
    ¼¼±Õ(¼º)ÀÇ
  • bacterial agglutination
    ¼¼±ÕÀÀÁý
  • bacterial antagonism
    ¼¼±Õ±æÇ×ÀÛ¿ë.
  • bacterial antigen
    ¼¼±Õ¼º Ç׿ø(¡­ù÷ê«).
  • bacterial antigen
    ¼¼±Õ(¼º)Ç׿ø
  • bacterial asthma
    ¼¼±Õ¼º õ½Ä(¡­ô·ãÓ).
  • bacterial calculi
    ¼¼±Õ¼º °á¼®(¡­Ì¿à´).
  • bacterial cell
    ±Õü, ±Õ¼¼Æ÷.
  • bacterial cell envelope
    ¼¼±Õ¿ÜÇÇ, ¼¼±Õ²®µ¥±â
  • bacterial cell membrane
    ¼¼±Õ¼¼Æ÷¸·
  • bacterial cell protein
    ±Õü´Ü¹é(Áú).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacterial ferredoxin
    ±Õ(ж)Æä·¹µ¶½Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BAC bacterial adherent colony; bacterial antigen complex; blood alcohol concentration; British Associati...
ABE Acute Bacterial Endocarditis
BE   1) Bacterial Endocarditis
  2) Base Excess
  3) Below the Elbo...
BV   1) Blood Volume
  2) Bacterial Vaginosis
NBTE Non-Bacterial Thrombotic Endocarditis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ABM Acute bacterial meningitis
BAC Bacterial Artificial Chromosome
BI Bacterial Index
BT Bacterial Translocation
BE Bacterial endocarditis
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y58
    Bacterial vaccines
    ¼¼±Õ¼º ¹é½Å
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°
  • acute bacterial meningitis
    ±Þ¼º ¼¼±Õ¼º ³ú¸·¿°
  • acute bacterial sialadenitis
    ±Þ¼º ¼¼±Õ¼º Ÿ¾×¼±¿°
  • bacterial
    ¼¼±Õ¼º, ¼¼±ÕÀÇ, ¼¼±Õ¼ºÀÇ
    ¼¼±Õ¿¡ °üÇÑ ¶Ç´Â ¼¼±Õ¿¡ ±âÀÎÇÑ.
  • bacterial adherence
    ¼¼±Õ Á¢Âø¼º
  • bacterial agglutination
    ¼¼±Õ¼º ÀÀÁý ¹ÝÀÀ
    ÀÔÀÚ »ó Ç׿øÀÌ Ç×ü¿Í °áÇÕÇÏ¿© À°¾ÈÀ¸·Î È®ÀÎÇÒ ¼ö ÀÖ´Â ÀÀÁý±«¸¦ Çü¼ºÇÏ´Â ¹ÝÀÀÀ» ÀÀÁý ¹ÝÀÀÀ̶ó°í ºÎ¸£¸é ±× Áß¿¡¼­ Ç׿øÀ¸·Î¼­ ¼¼±ÕÀ» »ç¿ëÇÑ °ÍÀÌ ¼¼±Õ ÀÀÁý ¹ÝÀÀÀÌ´Ù. ÀÀÁý ¹ÝÀÀ¿¡ °ü¿©ÇÏ´Â Ç×ü¸¦ ƯÈ÷ ÀÀÁý¼Ò, Ç׿øÀ» ÀÀÁý¿øÀ̶ó°í ºÎ¸£´Â ÀÏÀÌ ÀÖ´Ù. ¼¼±ÕÀÇ ±Õü Ç¥¸é¿¡´Â ÀÀÁý¿øÀ¸·Î¼­ ÀÛ¿ëÇÒ ¼ö ÀÖ´Â ¸¹ÀÌ Ç׿øÀÌ ¾Ë·ÁÁ® Àִµ¥ °¡Àå À¯¸íÇÑ °ÍÀ¸·Î¼­ Æí¸ð Ç׿øÀÎ H Ç׿ø, ±Õü Ç׿øÀ¸·Î¼­ÀÇ O Ç׿øÀÌ ÀÖ´Ù.
  • bacterial allergy
    ¼¼±Õ¼º ÀÌ»ó ¹Î°¨Áõ
    Ư¼öÇÑ ¼¼±Õ¼º Ç׿ø. À̰ÍÀº ƯÀÌÇÑ ¹Ì»ý¹°¿¡ ÀÇÇÑ ÀÌÀüÀÇ °¨¿°À¸·Î ÀÎÇÑ °ÍÀ¸·Î, ¼øÈ¯¼ºÀÇ Ç×ü´Â º¸ÀÌÁö ¾Ê´Â´Ù.
  • bacterial baccine
    ¼¼±Õ¼º ¹é½Å
  • bacterial coagulation
    ¼¼±Õ ÀÀÁý
  • bacterial endarteritis
    ¼¼±Õ¼º µ¿¸Æ³»¸·¿°
  • bacterial endotoxin
    ¼¼±Õ³» µ¶¼Ò
    ¼¼±Õ ¼¼Æ÷ º®¿¡ Á¸ÀçÇÏÁö¸¸, Á¤»ó ¼¼±Õ ¹è¾çÀÇ ¹«¼¼Æ÷ ¿©¾×¿¡´Â Á¸ÀçÇÏÁö ¾Ê´Â ³»¿­¼º µ¶¼Ò. ¿ø·¡ ±×¶÷ À½¼º ¼¼±Õ³»¿¡ ÀÖ°í ³»µ¶¼Ò¸¦ Çü¼ºÇϰí ÀÖ´Â ´Ù´çü´Â ±Õü Ç׿ø°ú µ¿ÀÏÇÑ ¹°ÁúÀÌ´Ù.
  • bacterial flora
    ¼¼±Õ±º
  • bacterial infection
    ¼¼±Õ °¨¿°, ¼¼±Õ¼º °¨¿°, ¹ÚÅ׸®¾Æ °¨¿°
    ¼¼±Õ¿¡ ÀÇÇÑ °¨¿°. °áÇÙ±Õ°ú °°ÀÌ ¸¸¼º À°¾ÆÁ¾¼º ¿°ÁõÀ» ÀÏÀ¸Å°´Â ÀϺÎÀÇ ¼¼±ÕÀ» Á¦¿ÜÇϰí´Â ´ëºÎºÐ È­³ó¼º ¿°ÁõÀ» ÀÏÀ¸Å°¸ç µå¹°°Ô °æ¸·¿Ü ¶Ç´Â °æ¸·ÇÏ ³ó¾çÀ» Çü¼ºÇϱ⵵ ÇÏÁö¸¸ ´ë°³ È­³ó¼º ¼ö¸·¿°, ±¹¼ÒÀû ³ú¿°, ³ú ³ó¾çÀ» Çü¼ºÇÑ´Ù.
  • bacterial palque coating
    ¼¼±Õ¼º ġŠÇǸ·
    ¼¼±Õ¿¡ ÀÇÇÑ Ä¡¾ÆÇ¥¸é ¹°ÁúÀÌ Ä§ÂøÇÑ °ÍÀ¸·Î ¿ìÄ¡, Ä¡¼® Çü¼ºÀÇ ÇÙ ±×¸®°í Ä¡ÁÖº´ µîÀ» À¯¹ßÇÏ´Â ¼¼±ÕÁõ½ÄÀÇ ¹èÁö°¡ µÈ´Ù.
  • bacterial phase
    ¼¼±Õ »ó
    ¼¼±ÕÀÌ ´«¿¡ º¸ÀÌ´Â ¾ç»ó.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
bacterial vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
aids vaccines Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced.
(12 Dec 1998)
cancer vaccines Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced.
(12 Dec 1998)
vaccines Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet.
(12 Dec 1998)
vaccines, attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.
(12 Dec 1998)
vaccines, combined Two or more vaccines in a single dosage form.
(12 Dec 1998)
vaccines, conjugate Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.
(12 Dec 1998)
vaccines, DNA Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.
(12 Dec 1998)
vaccines, inactivated Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
(12 Dec 1998)
vaccines, synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
(12 Dec 1998)
malaria vaccines Vaccines made from antigens arising from any of the four strains of plasmodium which cause malaria in humans, or from p. Berghei which causes malaria in rodents.
(12 Dec 1998)
viral hepatitis vaccines Any vaccine raised against any virus or viral derivative that causes hepatitis.
(12 Dec 1998)
viral vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
(12 Dec 1998)
rickettsial vaccines Vaccines for the prevention of diseases caused by various species of rickettsia.
(12 Dec 1998)
poliomyelitis vaccines Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine.
See: Salk vaccine.
(05 Mar 2000)
poliovirus vaccines Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine.
See: Salk vaccine.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Bacterial Vaccines - »õâ Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
    Synonyms : Bacterial Vaccine, Bacterin, Vaccine, Bacterial, Vaccines, Bacterial
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacterial
    ¼¼±Õ¿¡ ÀÇÇÑ
  • bacterial
    ¹ÚÅ׸®¾Æ(¼¼±Õ)ÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á